4//SEC Filing
Secora Michael 4
Accession 0001601830-24-000214
CIK 0001601830other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:26 PM ET
Size
13.4 KB
Accession
0001601830-24-000214
Insider Transaction Report
Form 4
Secora Michael
Chief Financial Officer
Transactions
- Tax Payment
Class A Common Stock
2024-11-15$6.17/sh−11,937$73,711→ 1,487,694 total
Holdings
- 348,380
Stock Option (Right to Buy)
Exercise: $10.09Exp: 2034-02-09→ Class A Common Stock (0 underlying) - 337,635
Stock Option (Right to Buy)
Exercise: $2.22Exp: 2030-03-03→ Class A Common Stock (0 underlying) - 404,857
Stock Option (Right to Buy)
Exercise: $8.55Exp: 2033-02-01→ Class A Common Stock (0 underlying) - 685,177
Stock Option (Right to Buy)
Exercise: $2.22Exp: 2030-03-03→ Class A Common Stock (0 underlying) - 116,684
Stock Option (Right to Buy)
Exercise: $11.40Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 3,914
Stock Option (Right to Buy)
Exercise: $11.40From: 2022-02-04Exp: 2032-02-04→ Class A Common Stock (0 underlying)
Footnotes (6)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F2]The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events.
- [F3]The option, originally for 1,125,000 shares, vests as to one forty-eighth (1/48th) of the shares subject to the award one month after March 1, 2020, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter.
- [F4]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F5]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F6]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001855980
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:26 PM ET
- Size
- 13.4 KB